Is your AAV payload impacting stability? Find out with Aura GT
14 Oct 2024Adeno-associated viruses (AAVs) have transformed gene therapies by enabling the targeted delivery of therapeutic genetic payloads. Aura GT™ from Halo Labs provides a low-volume, high-throughput, and sensitive methodology for comprehensive AAV formulation development. It helps to monitor nucleic acid leakage that can occur under common storage conditions and enables characterization of subvisible particles to improve sample stability.
Related products
Request Quote for All Products
Aura
Halo LabsAura® is the particle and aggregate detection system that combines Backgrounded Membrane Imaging which images 100% of your sample to give you count, size, and morphological information, with up to 2 channels of Fluorescence Membrane Microscopy. Identify if particles are protein or not with the first FMM channel and determine if your sample contains lipids, hydrophobic entities, or other aggregates of your choice with a second.
Aura CL
Halo LabsAura® CL systems couples Fluorescent Membrane Microscopy and Backgrounded Membrane Imaging to help you understand what’s in your cell therapy. It detects, counts, sizes, and IDs cellular aggregates and subvisible particles and ID’s cellular from other particles without any machine learning so you can maximize the purity, safety, and efficacy of your therapeutic.